The chemotherapeutic agent CP was encapsuled into CD64-NVs-aPD-L1 to facilitate CD8+ T cell forcefully and kill tumor cells through overcoming the obstacles of PD-1/PD-L1 axis and reverting Tregs suppression (Scheme 1). Here, CP is linked to neoplasm.